Search
for
Sort by
Research 661–690 of 1000+
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Modern Management Approaches for Alopecia Areata
- Alopecia Areata
- Alopecia areata: recognition, diagnosis and management
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- Alopecia universalis successfully treated at Dr. Batra's
- Markers of inflammation, metabolic disorders, and principles of treatment for alopecia areata in children
- New treatment modalities of alopecia areata
- “EFFECT OF JALUAKAVACHARAN IN MANAGEMENT OF INDRALUPTA WITH SPECIAL REFERENCE TO ALOPECIA AREATA-A CASE STUDY”
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Alopecia Areata Treatment: Past, Present, and Future
- A NEW COMBINATION OF KNOWN AGENTS FOR TREATMENT OF ALOPECIA AREATA: A CASE-SERIES STUDY.
- ALOPECIA AREATA: ASPECTOS FISIOLÓGICOS E AVANÇOS TERAPÊUTICOS – UMA REVISÃO DE LITERATURA
- The use of dupilumab for the treatment of alopecia areata
- An Effective Siddha Management For Alopecia Areata (Puzhuvettu) – A Case Report
- From joint pains to hair gains: baricitinib’s double duty for rheumatoid arthritis and alopecia areata
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- Whitaker syndrome: A case report of autoimmune polyendocrine syndrome type 1 with dilated cardiomyopathy
- ‘Ritlecitinib: unveiling hair regrowth for alopecia areata’
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- ALOPECIA AREATA PROFILING SHOWS LNCRNAS REGULATE THE SUPPRESSED EXPRESSION OF KERATIN.
- Ritlecitinib in severe alopecia areata: a profile of its use
- Alopecia Universalis after COVID-19 Vaccination: Case Report and Literature Review
- Traditional and Integrative Approaches to the Treatment of Alopecia
- Possible Integrative Approaches to Treatment of Alopecia: A Case Study Provides a Protocol Approach
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Myeloproliferative disorder associated with alopecia universalis
- 006 Exogenous IL-27 promotes immunosuppressive T cells and prevents the development of alopecia areata in C3H/HeJ mice